Lower extremity varicose veins in childhood and at a young age: Mechanism of development and specific features

Close metadata

Recommended articles:

Genetic factors in degenerative disc disease. Burdenko's Journal of Neurosurgery. 2024;(2):112-118

Endovenous Laser Ablation with Wavelengths 1940 and 1560 nm. Journal of Venous Disorders. 2024;(2):82-88

Surgical treatment of congenital and acquired internal carotid artery tortuosity in patients with ocular ischemic syndrome. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):272-278

A personalized genetic approach to surgical treatment of carotid artery tortuosity. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):436-444

In Russia more than 125,000 patients with various venous diseases, lower extremity varicose veins (LEVV) being predominant, were annually operated on. In recent years, there has been a trend toward younger patients with signs of LEVV. Screening studies have revealed the signs of the disease in 10—15% of high-school children. The high prevalence of LEVV as a whole and its younger onset in recent decades cause more attention to an investigation of the relationship between the development of varicose veins, in childhood and adolescence in particular, and genomic changes. Patients with varicose veins have been noted to have a genetically reduced capacity for contraction of the smooth muscle cells of the vein walls, their remodeling due to the increased synthesis of matrix Gla protein, overproduction of TGF-β1, a matrix metalloproteinase inhibitor, hyperhomocysteinemia, and mutations in the genes encoding the synthesis of thrombomodulin. Varicose vein transformation is considered to be a minor phenomenon of undifferentiated connective tissue dysplasia (UCTD) leading to failure of their walls due to abnormalities in the fibrous structures and extracellular matrix. Confirmation of the role of UCTD in the development of varicose veins will be able to provide an individual approach to treating patients and to choosing adequate postoperative therapy aimed at preventing a disease recurrence.

Keywords:

lower extremity varicose veins

genetic factors

undifferentiated connective tissue dysplasia

mechanisms in varicose vein development

Authors:

Studennikova V.V.

Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Severgina L.O.

Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Dziundzia A.N.

GBOU VPO Pervyĭ MGMU im. I.M. Sechenova, Universitetskaia klinicheskaia bol'nitsa #1, Klinika aortal'noĭ i serdechno-sosudistoĭ khirurgii, Moskva

Korovin I.A.

Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

List of references:

Doronin IV. Diagnostics and treatment of vein varicosity of lower extremities in teenagers. Diss. Rostov-na-Donu; 2012. (In Russ.).
Kirienko AI, Bogachev VYu, Zolotukhin IA. Minimal invasive surgery of vein varicosity of lower extremities. Ambulatornaya khirurgiya. Statsionarozameshchayushchie tekhnologii. 2003;3(11):71. (In Russ.).
Savel’ev VS, ed. Phlebology. A guide for doctors [Flebologiya. Rukovodstvo dlya vrachei]. Moscow: Meditsina; 2001:606-610. (In Russ.).
http://lekarius.ru/
Lee B, Andrade M, Bergan J, Boccardo F, Campisi C, Damstra R, et al. Diagnosis and treatment of primary lymphedema. Consensus document of the international union of phlebology (IUP)-2009. Int Angiol. 2010;29(5):454-470.
Osipov DV. Diagnostics of chronic venous insufficiency of lower extremities in teenagers. Diss. Kazan’; 2007. (In Russ.).
Stoiko YuM, Shaidakov EV, Sabel’nikov VV. Phlebosclerotic treatment of varicosity and teleangioectasies. Angiologiya i sosudistaya khirurgiya. 2001;2:49-52. (In Russ.).
Shevchenko YuL, Lyadov KV, Stoiko YuM, et al. Evolution and revolution in surgery of CVI. In: Standards of diagnostics and treatment of chronic venous insufficiency [Standarty diagnostiki i lecheniya khronicheskoi venoznoi nedostatochnosti]: Materialy simpoziuma V konferentsii assotsiatsii flebologov Rossii. Moscow: 2004:15-18. (In Russ.).
Shulutko AM, Krylov AYu, Gogokhiya TR. Modern diagnostic and treatment principles of patients with recidivous varicosity of lower extremities. Angiologiya i sosudistaya khirurgiya. 2003;3(Suppl): 357-358. (In Russ.).
Pocock ES, Alsaigh T, Mazor R, Schmid-Schönbein GW. Cellular and molecular basis of venous insufficiency. Vasc Cell. 2014;6(1):24. https://doi.org/10.1186/s13221-014-0024-5
Nicolaides AN. Investigation of chronic venous insufficiency: a consensus statement (France, March 5-9, 1997). Circulation. 2000;102(20):E126-E163.
Xiao Y, Huang Z, Yin H, Lin Y, Wang S. In vitro differences between smooth muscle cells derived from varicose veins and normal veins. J Vasc Surg. 2009;50(5):1149-1154. https://doi.org/10.1016/j.jvs.2009.06.048
Munger SJ, Kanady JD, Simon AM. Absence of venous valves in mice lacking Connexin37. Dev Biol. 2013;373(2):338-348. https://doi.org/10.1016/j.ydbio.2012.10.032
Reed KE, Westphale EM, Larson DM, Wang HZ, Veenstra RD, Beyer EC. Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein. J Clin Invest. 1993;91(3):997-1004. https://doi.org/10.1172/jci116321
Le Flem L, Mennen L, Aubry ML, Aiach M, Scarabin PY, Emmerich J, Alhenc-Gelas M. Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol. 2001;21(3):445-451.
Cario-Toumaniantz C, Boularan C, Schurgers LJ, Heymann MF, Le Cunff M, Leger J, et al. Identification of differentially expressed genes in human varicose veins: involvement of matrix Gla protein in extracellular matrix remodeling. J Vasc Res. 2007;44(6):444-459. https://doi.org/10.1159/000106189
Sam RC, Burns PJ, Hobbs SD, Marshall T, Wilmink AB, Silverman SH, Bradbury AW. The prevalence of hyperhomocysteinemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency. J Vasc Surg. 2003;38(5):904-908. https://doi.org/10.1016/s0741
Surendran S, Ramegowda KS, Suresh A, Binil Raj SS, Lakkappa RK, Kamalapurkar G, et al. Arterialization and anomalous vein wall remodeling in varicose veins is associated with upregulated FoxC2-Dll4 pathway. Lab Invest. 2016; 96(4):399-408. https://doi.org/10.1038/labinvest.2015.167
Mellor RH, Brice G, Stanton AW, French J, Smith A, Jeffery S, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 2007;115(14):1912-1920. https://doi.org/10.1161/circulationaha.106.675348
Limaye N, Kangas J, Mendola A, Godfraind C, Schlögel MJ, Helaers R, et al. Somatic activating PIK3CA mutations cause venous malformation. Am J Hum Genet. 2015;97(6):914-921. https://doi.org/10.1016/j.ajhg.2015.11.011
Naik B, Kumar M, Khanna AK, Suman PK. Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1, matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation. Indian J Pathol Microbiol. 2016;59(1):25-30. https://doi.org/10.4103/0377-4929.178217
Kucukguven A, Khalil RA. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets. 2013;14(3):287-324.
Metcalfe MJ, Baker DM, Turmaine M, Burnstock G. Alterations in purinoceptor expression in human long saphenous vein during varicose disease. Eur J Vasc Endovasc Surg. 2007;33(2):239-250. https://doi.org/10.1016/j.ejvs.2006.09.007
Kadurina TI. Hereditary collagenopahties: clinical symptoms, diagnostics, treatment, patient observation [Nasledstvennye kollagenopatii: klinika, diagnostika, lechenie, dispanserizatsiya]. St. Petersburg: Nevskii dialect; 2000. (In Russ.).
Cheah KS. Collagen genes and inherited connective tissue disease. Biochem J. 1985;229(2):287-303.
Henney AM, Tsipouras P, Schwartz RC, Child AH, Devereux RB, Leech GJ. Genetic evidence that mutations in the COL1A1, COL1A2, COL3A1, or COL5A2 collagen genes are not responsible for mitral valve prolapse. Br Heart J. 1989;61(3):292-299.
Handler CE, Child A, Light WD. Mitral valve prolapse, aortic compliance, and skin collagen injoint hypermobility syndrome. Br Heart J. 1985;54(5):501-508.
Maslen CL, Corson GM, Maddox BK, Glanville RW, Sakai LY. Partial sequence of a candidate gene for the Marfan syndrome. Nature. 1991;352(6333):334-337. https://doi.org/10.1038/352334a0
Milewicz DM, Urban Z, Boyd C. Genetic disorders of the elastic fiber system. Matrix Biol. 2000;19(6):471-480.
Trisvetova EL. Bova AA, Feshchenko SP. Inborn connective tissue dysplasias: clinical and molecular diagnostics. Meditsinskie novosti. 2000;5:23-29. (In Russ.).
Tyabut TD, Karatysh OM. Undifferentiated connective tissue dysplasia. Sovremennaya revmatologiya. 2009;3(2):19-23. (In Russ.). https://doi.org/10.14412/1996-7012-2009-534
Alarcon GS. Unclassified or undifferentiated connective tissue disease. Clin Rheumatol. 2000;4(1):125-137. https://doi.org/10.1053/berh.1999.0081
Pyeritz RE. Disorders of fibrillins and microfibrilogenesis: Marfan syndrome, MASS phenotype, contratural arachnoductyly and related conditions. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimoin’s principles and practice of medical genetics. 3rd ed. New York: Churchill Livingstone; 1996:301.
Kadurina TI, Korzhenevskaya MA, Mikheev VS. Family genetic analysis of generalized connective tissue dysplasia including MASS-phenotype. Arterial’naya gipertenziya. 1999;5(1):26-27. (In Russ.).
Makolkin VI, Podzolkov VI, Rodionov AV, Sheyanov MV, Samoilenko VV, Napalkov DA. Clinical symptom polymorphism in undifferentiated connective tissue syndrome. Terapevticheskii arkhiv. 2004; 76(11):77-80. (In Russ.).
Nechaeva GI, Viktorova IA. Connective tissue dysplasia: terminology, diagnostics, patient management [Displaziya soedinitel’noi tkani: terminologiya, diagnostika, taktika vedeniya patsientov]. Omsk: «Tipografiya BLANKOM»; 2007. (In Russ.).
Kallenberg CG. Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions. Curr Opin Rheumatol. 1995;7(6):568-573.
Potapov MP, Potapov PP, Staver EV, Mazepina LS. Varicosity vein of lower extremities as undifferentiated connective tissue manifestation. Angiologiya i sosudistaya khirurgiya. 2016;22(1):97-102. (In Russ.).
Potapov MP, Staver EV. Clinical and laboratory criteria for non-specific connective tissue dysplasia as a predictors of recurrent lower limb varicose veins. Flebologiya. 2013;4:25-31. (In Russ.).
Bogachev VYu, Zolotukhin IA, Bryushkov AYu, Zhuravleva OV. Phlebosclerotic treatment of varicous veins of lower extremities with use of «foam-form» technic. Angiologiya i sosudistaya khirurgiya. 2003;9(2):81-85. (In Russ.).
Tsarev OA, Anisimov AYu, Zakharov NN. Prognosis of complicated clinical course of varicose veins of lower extremities on the basis of analysis of phenotypic characteristics of connective tissue dysplasia. Saratovskii nauchno-meditsinskii zhurnal. 2015;11(4):587-591. (In Russ.).

Close metadata